Ronan Hsieh is an Oncology physician affiliated with Swedish Medical Center. OpenAlex indexes 50 publications with 472 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year202534 payments$27,894openpaymentsdata.cms.gov ↗
- BeOne Medicines USA, Inc.Program year202522 payments$25,472openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
41.1%Opioid Agonist21%Loperamide100%Part D≥22 patientsSerotonin-3 Receptor Antagonist20.2%Ondansetron Hcl100%Part D≥23 patientsNervous system
34.7%Phenothiazine24.2%Prochlorperazine Maleate100%Part D≥24 patientsOpioid Agonist10.5%Oxycodone Hcl100%Part D<11 patientsCardiovascular
24.2%Antiarrhythmic24.2%Lidocaine-Prilocaine100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparative genomic profiles of <i>ERBB2/HER2</i> -mutant and -amplified colorectal cancers: A comprehensive cohort study.
Journal of Clinical Oncology
2026 - Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer
Technology in Cancer Research & Treatment
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Anne Lipke, MD
Swedish Medical Center
Jens Chapman, MD
Swedish Medical Center
Eric Vallieres, MD
Swedish Medical Center
Rod Oskouian, MD
Swedish Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”